Brind.

Concentra Biosciences announced its acquisition of iTeos Therapeutics.

1 report, 1 independent Updated Jul 21
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Concentra Biosciences announced its acquisition of iTeos Therapeutics.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • GlobeNewswireiTeos Therapeutics Enters into Agreement to Be Acquired by Concentra Biosciences for $10.047 in Cash per Share Plus a Contingent Value Right WATERTOWN, Mass. and GOSSELIES, Belgium, July 21, 2025 (GL